Literature DB >> 20134433

Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA.

Michal Minczuk1, Paulina Kolasinska-Zwierz, Michael P Murphy, Monika A Papworth.   

Abstract

Engineered zinc-finger proteins (ZFPs) are hybrid proteins developed to direct various effector domains (EDs) of choice to predetermined DNA sequences. They are used to alter gene expression and to modify DNA in a sequence-specific manner in vivo and in vitro. Until now, ZFPs have mostly been used to target DNA sites in nuclear genomes. This protocol describes how to adapt engineered ZFP technology to specifically modify the mammalian mitochondrial genome. The first step describes how to construct mitochondrially targeted ZFPs (mtZFPs) so that they are efficiently imported into mammalian mitochondria. In the second step, methods to test the basic properties of mtZFPs in vitro are described. Finally, we outline how the mtZFPs can be transiently transfected into mammalian cells and their mitochondrial import tested by both immunofluorescence and biochemical methods. The protocol can be completed within a week, although time-consuming DNA cloning steps may extend this.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134433     DOI: 10.1038/nprot.2009.245

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  33 in total

Review 1.  Designer zinc-finger proteins and their applications.

Authors:  Monika Papworth; Paulina Kolasinska; Michal Minczuk
Journal:  Gene       Date:  2005-11-17       Impact factor: 3.688

2.  Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly.

Authors:  David A Wright; Stacey Thibodeau-Beganny; Jeffry D Sander; Ronnie J Winfrey; Andrew S Hirsh; Magdalena Eichtinger; Fengli Fu; Matthew H Porteus; Drena Dobbs; Daniel F Voytas; J Keith Joung
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

4.  Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids.

Authors:  R W Taylor; P F Chinnery; D M Turnbull; R N Lightowlers
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

5.  Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors.

Authors:  Monika Papworth; Michael Moore; Mark Isalan; Michal Minczuk; Yen Choo; Aaron Klug
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

6.  An affinity-based scoring scheme for predicting DNA-binding activities of modularly assembled zinc-finger proteins.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2008-12-04       Impact factor: 16.971

7.  Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.

Authors:  Yolanda Santiago; Edmond Chan; Pei-Qi Liu; Salvatore Orlando; Lin Zhang; Fyodor D Urnov; Michael C Holmes; Dmitry Guschin; Adam Waite; Jeffrey C Miller; Edward J Rebar; Philip D Gregory; Aaron Klug; Trevor N Collingwood
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-21       Impact factor: 11.205

8.  Overlap of nuclear localisation signal and specific DNA-binding residues within the zinc finger domain of PacC.

Authors:  Javier Fernández-Martínez; Christopher V Brown; Eliecer Díez; Joan Tilburn; Herbert N Arst; Miguel A Peñalva; Eduardo A Espeso
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

9.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

10.  Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.

Authors:  Michal Minczuk; Monika A Papworth; Jeffrey C Miller; Michael P Murphy; Aaron Klug
Journal:  Nucleic Acids Res       Date:  2008-05-29       Impact factor: 16.971

View more
  24 in total

1.  An upstream open reading frame and the context of the two AUG codons affect the abundance of mitochondrial and nuclear RNase H1.

Authors:  Yutaka Suzuki; J Bradley Holmes; Susana M Cerritelli; Kiran Sakhuja; Michal Minczuk; Ian J Holt; Robert J Crouch
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

Review 2.  Manipulating and elucidating mitochondrial gene expression with engineered proteins.

Authors:  Christopher P Wallis; Louis H Scott; Aleksandra Filipovska; Oliver Rackham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-12-02       Impact factor: 6.237

Review 3.  Manipulating mitochondrial genomes in the clinic: playing by different rules.

Authors:  Carlos T Moraes; Sandra R Bacman; Sion L Williams
Journal:  Trends Cell Biol       Date:  2014-04       Impact factor: 20.808

Review 4.  The potential of mitochondrial genome engineering.

Authors:  Pedro Silva-Pinheiro; Michal Minczuk
Journal:  Nat Rev Genet       Date:  2021-12-02       Impact factor: 53.242

5.  Targeted Epigenetic Remodeling of the Cdk5 Gene in Nucleus Accumbens Regulates Cocaine- and Stress-Evoked Behavior.

Authors:  Elizabeth A Heller; Peter J Hamilton; Dominika D Burek; Sonia I Lombroso; Catherine J Peña; Rachael L Neve; Eric J Nestler
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

6.  PDE12 removes mitochondrial RNA poly(A) tails and controls translation in human mitochondria.

Authors:  Joanna Rorbach; Thomas J J Nicholls; Michal Minczuk
Journal:  Nucleic Acids Res       Date:  2011-06-11       Impact factor: 16.971

7.  C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome.

Authors:  Joanna Rorbach; Payam A Gammage; Michal Minczuk
Journal:  Nucleic Acids Res       Date:  2012-01-11       Impact factor: 16.971

8.  TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies.

Authors:  Christopher A Powell; Robert Kopajtich; Aaron R D'Souza; Joanna Rorbach; Laura S Kremer; Ralf A Husain; Cristina Dallabona; Claudia Donnini; Charlotte L Alston; Helen Griffin; Angela Pyle; Patrick F Chinnery; Tim M Strom; Thomas Meitinger; Richard J Rodenburg; Gudrun Schottmann; Markus Schuelke; Nadine Romain; Ronald G Haller; Ileana Ferrero; Tobias B Haack; Robert W Taylor; Holger Prokisch; Michal Minczuk
Journal:  Am J Hum Genet       Date:  2015-07-16       Impact factor: 11.025

9.  Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.

Authors:  Payam A Gammage; Edoardo Gaude; Lindsey Van Haute; Pedro Rebelo-Guiomar; Christopher B Jackson; Joanna Rorbach; Marcin L Pekalski; Alan J Robinson; Marine Charpentier; Jean-Paul Concordet; Christian Frezza; Michal Minczuk
Journal:  Nucleic Acids Res       Date:  2016-07-27       Impact factor: 16.971

Review 10.  Engineering Genetic Systems for Treating Mitochondrial Diseases.

Authors:  Yoon-Ha Jang; Sae Ryun Ahn; Ji-Yeon Shim; Kwang-Il Lim
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.